Initial Testing (Stage 1) of Temozolomide by the Pediatric Preclinical Testing Program

Eitemau Tebyg

• Initial Testing (Stage 1) of the Notch Inhibitor PF-03084014, by the Pediatric Preclinical Testing Program
  gan: Carol, Hernan, et al.
  Cyhoeddwyd: (2014)
• Synergistic Activity of PARP Inhibition by Talazoparib (BMN 673) with Temozolomide in Pediatric Cancer Models in the Pediatric Preclinical Testing Program
  gan: Smith, Malcolm A., et al.
  Cyhoeddwyd: (2014)
• Initial Testing (Stage 1) of BAL101553, a Novel Tubulin Binding Agent, by the Pediatric Preclinical Testing Program
  gan: Kolb, E. Anders, et al.
  Cyhoeddwyd: (2014)
• Initial Testing of VS-4718, a novel inhibitor of Focal Adhesion Kinase (FAK), against pediatric tumor models by the Pediatric Preclinical Testing Program
  gan: Kurmasheva, Raushan T., et al.
  Cyhoeddwyd: (2016)
• Initial Testing (Stage 1) the Pediatric Preclinical Testing Program of RO4929097, a γ-Secretase Inhibitor Targeting Notch Signaling
  gan: Kolb, E. Anders, et al.
  Cyhoeddwyd: (2011)